Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cardiff Oncology Inc CRDF

Healthcare Biotechnology
Cardiff Oncology, Inc. is a clinical-stage biotechnology company. It is leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the unmet medical need. It is focused on clinical programs in indications, such as RAS-mutated metastatic colorectal cancer (mCRC), and in investigator-initiated trials in metastatic pancreatic ductal... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CRDF)

Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update

GlobeNewswire 7 days ago

Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC

GlobeNewswire October 30, 2024

Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update

GlobeNewswire August 8, 2024

Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update

GlobeNewswire August 1, 2024

Cardiff Oncology to Present at the Jefferies Healthcare Conference

GlobeNewswire May 29, 2024

Cardiff Oncology to Present at Upcoming Investor Conferences in May

GlobeNewswire May 13, 2024

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update

GlobeNewswire May 2, 2024

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

GlobeNewswire April 25, 2024

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

GlobeNewswire April 8, 2024
View More News ››

Opinion & Analysis (NDAQ:CRDF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CRDF)

Enjoying your "capital gains"?

So you people enjoying your "capital gains" from a couple of days ago? Lol, "capital gains."
Pumpsydumpsy - June 28, 2024

Cardiff Oncology Inc. (NASDAQ: CRDF) Making Surprising Moves

NEWS: $CRDF Cardiff Oncology Inc. (NASDAQ: CRDF) Making Surprising Moves in Monday SessionCardiff Oncology, Inc. (NASDAQ: CRDF) has...
whytestocks - April 29, 2024

Finding Long Term Penny Stocks Investments? 3 Tips

JUST IN: $CRDF Finding Long Term Penny Stocks Investments? 3 Tips2024-03-04 06:51:00 ET 3 Tips for Making a Long Term Penny Stocks...
whytestocks - March 4, 2024

Looking to add a position

Stock looks like a buy at these prices
biggdeal - May 7, 2021

RE:Small add here.....

News release this a.m........added to position.  Cheers !
Iseneschal - January 26, 2021

Small add here.....

will add on weakness if continuation occurs. Cheers!
Iseneschal - January 19, 2021
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »